UniSa - IRIS Institutional Research Information System

TRIGGIANI, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.056
AS - Asia 12.042
EU - Europa 3.927
SA - Sud America 1.114
Continente sconosciuto - Info sul continente non disponibili 326
AF - Africa 136
OC - Oceania 17
Totale 29.618
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.814
HK - Hong Kong 6.892
SG - Singapore 2.222
IT - Italia 1.748
CN - Cina 1.063
BR - Brasile 831
VN - Vietnam 818
UA - Ucraina 510
RU - Federazione Russa 358
DE - Germania 335
TR - Turchia 255
FR - Francia 219
IE - Irlanda 213
KR - Corea 194
BD - Bangladesh 159
AR - Argentina 132
FI - Finlandia 125
CA - Canada 114
GB - Regno Unito 101
IN - India 99
SE - Svezia 90
IQ - Iraq 66
MX - Messico 52
ES - Italia 42
CO - Colombia 39
EC - Ecuador 39
ID - Indonesia 39
ZA - Sudafrica 36
JP - Giappone 35
AT - Austria 34
PK - Pakistan 33
PL - Polonia 33
NL - Olanda 26
SA - Arabia Saudita 22
MA - Marocco 20
PY - Paraguay 18
VE - Venezuela 18
AE - Emirati Arabi Uniti 17
JM - Giamaica 17
UZ - Uzbekistan 16
CZ - Repubblica Ceca 14
JO - Giordania 14
MY - Malesia 14
CR - Costa Rica 13
KE - Kenya 13
CL - Cile 12
PE - Perù 12
EG - Egitto 10
HN - Honduras 10
NZ - Nuova Zelanda 10
PH - Filippine 10
IL - Israele 9
ET - Etiopia 8
KZ - Kazakistan 8
LT - Lituania 8
UY - Uruguay 8
AL - Albania 7
AU - Australia 7
CH - Svizzera 7
DZ - Algeria 7
NP - Nepal 7
PA - Panama 7
SY - Repubblica araba siriana 7
TN - Tunisia 7
AZ - Azerbaigian 6
BE - Belgio 6
NI - Nicaragua 6
PS - Palestinian Territory 6
BG - Bulgaria 5
BY - Bielorussia 5
GR - Grecia 5
MD - Moldavia 5
PT - Portogallo 5
RS - Serbia 5
AM - Armenia 4
BO - Bolivia 4
CI - Costa d'Avorio 4
EU - Europa 4
GT - Guatemala 4
MK - Macedonia 4
SN - Senegal 4
SV - El Salvador 4
BA - Bosnia-Erzegovina 3
GN - Guinea 3
HU - Ungheria 3
LB - Libano 3
NG - Nigeria 3
OM - Oman 3
SI - Slovenia 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BF - Burkina Faso 2
BM - Bermuda 2
BN - Brunei Darussalam 2
BZ - Belize 2
CG - Congo 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GP - Guadalupe 2
Totale 29.254
Salva come PNG Salva come JPEG
Città #
Hong Kong 6.881
Ann Arbor 2.093
Woodbridge 1.132
Singapore 1.073
San Jose 816
Milan 786
Chandler 699
Jacksonville 666
Ashburn 659
Princeton 628
Dallas 581
Houston 559
Wilmington 396
Dong Ket 326
The Dalles 283
Council Bluffs 261
Izmir 223
Beijing 220
Rome 214
Dublin 209
Lauterbourg 197
Ho Chi Minh City 175
Los Angeles 158
Andover 147
Nanjing 133
New York 123
Santa Clara 121
Boardman 116
Moscow 106
Pellezzano 103
Hanoi 99
Munich 79
Naples 74
Memphis 72
São Paulo 64
Nuremberg 61
Washington 60
Salerno 55
Figino 51
Turin 51
Düsseldorf 50
Shenyang 49
Fairfield 46
Changsha 45
Columbus 43
Hebei 42
Buenos Aires 41
Norwalk 40
Jiaxing 38
Nanchang 37
Redwood City 37
Chicago 36
Orem 32
Brooklyn 31
Montreal 31
Tokyo 30
Buffalo 29
Atlanta 28
Haiphong 28
Warsaw 28
Baghdad 27
Dearborn 27
Rio de Janeiro 27
Seattle 27
Tianjin 26
Da Nang 24
Boston 23
Denver 22
Frankfurt am Main 22
Lappeenranta 22
Turku 22
London 21
Mexico City 21
Phoenix 21
Poplar 19
Mestre 18
Johannesburg 17
Quito 17
Stockholm 17
Belo Horizonte 16
Pune 16
San Francisco 16
Toronto 16
Charlotte 15
Vienna 15
Curitiba 14
Seoul 14
Shanghai 14
Amman 13
Asunción 13
Chennai 13
Dhaka 13
Newark 12
Palermo 12
San Diego 12
Brasília 11
Cambridge 11
Nairobi 11
Raleigh 11
Tashkent 11
Totale 22.190
Salva come PNG Salva come JPEG
Nome #
Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project) 966
La triptasi sierica nella diagnosi di mastocitosi sistemica in pazienti adulti senza lesioni cutanee 661
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 597
Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control 576
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical Practice 530
Fragments of truth: T-cell targets of polyclonal immunoglobulins in autoimmune diseases 506
Triggers and prodromal symptoms of angioedema attacks in patients with hereditary angioedema 392
Control of arachidonate levels within inflammatory cells. 382
A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy 369
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: Data from the Campania Rare Disease Registry 361
Anaphylaxis and cardiovascular diseases 335
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 324
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT 293
Integrated care pathways for airway diseases (AIRWAYS-ICPs) 283
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis 280
Immunoglobulin G (IgG) anticardiolipin antibodies and recurrent cardiovascular events. A systematic review and Bayesian meta-regression analysis 241
Multidisciplinary challenges inmastocytosis and how to address with personalizedmedicine approaches 227
Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: A Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & Immunology 222
A review of hereditary angioedema and recombinant human C1-inhibitor treatment 220
Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group 219
Characterization of platelet-activating factor synthesized by normal and granulocyte-macrophage colony-stimulating factor-primed human eosinophils. 218
Diagnostic and therapeutic management of hereditary angioedema due to C1-inhibitor deficiency: The Italian experience 213
Factors that influence the proportions of platelet-activating factor and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine synthesized by the mast cell. 211
A randomised, placebo-controlled, double blind phase III study of the efficacy and safety of recombinant human C1 inhibitor for the treatment of acute attacks in patients with hereditary angioedema 211
Heterogeneity of human Fc epsilon RI-bearing cells. 203
Antigen-induced generation of lyso-phospholipids in human airways. 187
Allergia alimentare e probiotici: nuovi aspetti sulle interazioni tra il sistema immunitario ed i batteri commensali intestinali 185
Secretory phospholipases A2 activate selective functions in human eosinophils 180
Activation of human basophils by staphylococcal protein A. I. The role of cyclic AMP, arachidonic acid metabolites, microtubules and microfilaments. 175
Stress and Psychological Factors in the Variable Clinical Phenotype of Hereditary Angioedema in Children: A Pilot Study 174
Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium 170
Arachidonic acid metabolism during antigen and ionophore activation of the mouse bone marrow derived mast cell. 169
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation 166
Advances in the classification and treatment of mastocytosis: Current status and outlook toward the future 166
Activation of human inflammatory cells by secreted phospholipases A2 160
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 160
Antileucotrieni nell'asma bronchiale: bilancio e prospettive 159
Current concepts on diagnosis and treatment of mastocytosis. 158
Work productivity in rhinitis using cell phones: The MASK pilot study 158
Activation of cytokine production by secreted phospholipase A2 in human lung macrophages expressing the M-type receptor 155
Molecular and cellular biology of mast cells and basophils. 151
Enhanced Expression of CD47 Is Associated With Off-Target Resistance to Tyrosine Kinase Inhibitor Gefitinib in NSCLC 151
A unique case of angioedema with anti-C1 inhibitor antibodies and normal C1 inhibitor levels 146
L'acido ialuronico nella regolazione delle risposte infiammatorie ed immunologiche 143
Non lymphomatous clonal B-Cell populations in enlarged lymph nodes in acquired immunodeficiency syndrome. 143
Editorial overview: Immunomodulation: Modulation of the immune system: Per aspera ad astra 140
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis 140
Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases 138
A Survey of Clinical Features of Allergic Rhinitis in Adults 137
Biochemical functions of a pool of arachidonic acid associated with triglycerides in human inflammatory cells. 137
Home Therapy with Plasma-Derived C1 Inhibitor: A Strategy to Improve Clinical Outcomes and Costs in Hereditary Angioedema 137
Human Macrophages and Monocytes Express Functional Na+/Ca2+ Exchangers 1 and 3Sodium Calcium Exchange: A Growing Spectrum of Pathophysiological Implications 132
Biomarkers for evaluation of mast cell and basophil activation 132
Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study 131
360 degree perspective on allergic rhinitis management in Italy: A survey of GPs, pharmacists and patients 131
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions 131
Benzene metabolites inhibit the release of proinflammatory mediators and cytokines from human basophils 130
Assay of antibody to group A streptococcal carbohydrate by enzyme-linked immunosorbent assay. 129
Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema 129
Pharmacological modulation of human mast cells and basophils 129
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement 128
Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor. 127
Biological effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil. 127
Evaluation of vaccination safety in children with mastocytosis 127
Relative amounts of 1-O-alkyl- and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in stimulated endothelial cells. 126
Perioperative anaphylactic risk score for risk-oriented premedication. 126
Are mast cells MASTers in HIV-1 infection? 126
Research needs in allergy: an EAACI position paper, in collaboration with EFA 125
What we should learn from the London Olympics 125
Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal 124
Mast cells as effector cells of innate immunity and regulators of adaptive immunity 124
European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives 121
Molecular diagnosis and the Italian Board for ISAC. 120
Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation. 119
Inhibition of IgE-mediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin. 119
Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes. 119
Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool. 118
Sensitization to Common and Uncommon Pets or Other Furry Animals: Which May Be Common Mechanisms? 117
Differential roles for triglyceride and phospholipid pools of arachidonic acid in human lung macrophages. 116
Arachidonic acid remodeling in human inflammatory cells migrating to the lung in vivo. 116
Oxidative stress markers are increased in patients with mastocytosis 115
Role of human FcεRI+ cells in HIV-1 infection 115
Management of chronic spontaneous urticaria: practical parameters 114
Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis 114
HIV-1 envelope gp41 peptides promote migration of human FcεRI+ cells and inhibit IL-13 synthesis through interaction with formyl peptide receptors 114
Simplexide Induces CD1d-Dependent Cytokine and Chemokine Production from Human Monocytes 113
Role of human mast cells and basophils in bronchial asthma. 113
ARIA Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology 113
Bone Marrow Failure Syndromes, Overlapping Diseases with a Common Cytokine Signature 112
Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A. 111
Mutational Spectrum of the C1 Inhibitor Gene in a Cohort of Italian Patients with Hereditary Angioedema: Description of Nine Novel Mutations 111
Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis 111
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients 111
Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: An expert opinion 111
Expression and function of angiopoietins and their tie receptors in human basophils and mast cells 110
Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study. 109
International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency 109
Inhibition of secretory phospholipase A2-induced cytokine production in human lung macrophages by budesonide 108
Influence of immunologic activation and cellular fatty acid levels on the catabolism of platelet-activating factor within the murine mast cell (PT-18). 107
Metabolism of platelet-activating factor in the guinea-pig heart. 107
Totale 18.977
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.577
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.577
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.038 0 3 4 18 10 19 9 44 166 139 137 489
2022/20231.740 184 104 59 200 244 388 12 165 260 6 93 25
2023/20241.002 82 110 122 49 97 174 23 44 11 40 47 203
2024/20252.428 79 34 33 96 109 283 353 246 465 199 281 250
2025/202615.442 1.342 3.676 3.071 568 1.025 558 1.660 361 410 867 361 1.543
2026/2027778 596 182 0 0 0 0 0 0 0 0 0 0
Totale 29.618